XLV vs. ARKF

Last updated Jun 14, 2026

XLV (State Street Health Care Select Sector SPDR ETF) and ARKF (ARK Fintech Innovation ETF) are both exchange-traded funds - XLV is a Health & Biotech Equities fund tracking the Health Care Select Sector Index, while ARKF is a Blockchain fund actively managed by ARK. XLV is passively managed, while ARKF is actively managed. Over the past 5 years, XLV returned 6.00%/yr vs -5.06%/yr for ARKF. At a 0.39 correlation, their price movements are largely independent. XLV charges 0.08%/yr vs 0.75%/yr for ARKF.

Performance

XLV vs. ARKF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in State Street Health Care Select Sector SPDR ETF (XLV) and ARK Fintech Innovation ETF (ARKF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XLV achieves a -0.23% return, which is significantly higher than ARKF's -18.31% return.

XLV

• 1D: -0.18%
• 1M: 4.90%
• YTD: -0.23%
• 6M: 0.67%
• 1Y: 15.00%
• 3Y*: 7.12%
• 5Y*: 6.00%
• 10Y*: 9.81%

ARKF

• 1D: 0.00%
• 1M: -7.34%
• YTD: -18.31%
• 6M: -21.31%
• 1Y: -11.63%
• 3Y*: 23.97%
• 5Y*: -5.06%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XLV vs. ARKF - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
XLV State Street Health Care Select Sector SPDR ETF	-0.23%	14.50%	2.47%	2.07%	-2.08%	26.04%	13.30%	14.82%
ARKF ARK Fintech Innovation ETF	-18.31%	28.67%	34.34%	93.27%	-65.07%	-17.82%	108.03%	20.45%

Correlation

The correlation between XLV and ARKF is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.25
Correlation (5Y) Calculated over the trailing 5-year period	0.35
Correlation (All Time) Calculated using the full available price history since Feb 4, 2019	0.39

Over the past year, the correlation between XLV and ARKF has dropped to 0.14 - well below their long-term average of 0.39, suggesting their price drivers have been diverging.

XLV vs. ARKF - Sectors Allocation Comparison

Sectors	XLV	ARKF
Healthcare	100.0%	0.1%
Basic Materials	-	-
Communication Services	-	9.8%
Consumer Cyclical	-	13.4%
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	25.2%
Industrials	-	-
Real Estate	-	-
Technology	-	39.8%
Utilities	-	-

Return for Risk

XLV vs. ARKF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XLV

XLV Risk / Return Rank: 30
XLV Sharpe Ratio Rank: 30
XLV Sortino Ratio Rank: 33
XLV Omega Ratio Rank: 28
XLV Calmar Ratio Rank: 32
XLV Martin Ratio Rank: 27

ARKF

ARKF Risk / Return Rank: 7
ARKF Sharpe Ratio Rank: 6
ARKF Sortino Ratio Rank: 7
ARKF Omega Ratio Rank: 7
ARKF Calmar Ratio Rank: 7
ARKF Martin Ratio Rank: 7

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XLV vs. ARKF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for State Street Health Care Select Sector SPDR ETF (XLV) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XLV	ARKF	Difference
Sharpe ratio: Return per unit of total volatility	0.97	-0.35	+1.32
Sortino ratio: Return per unit of downside risk	1.55	-0.28	+1.83
Omega ratio: Gain probability vs. loss probability	1.17	0.97	+0.21
Calmar ratio: Return relative to maximum drawdown	1.38	-0.31	+1.69
Martin ratio: Return relative to average drawdown	3.31	-0.57	+3.88

XLV vs. ARKF - Sharpe Ratio Comparison

The current XLV Sharpe Ratio is 0.97, which is higher than the ARKF Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of XLV and ARKF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

XLV vs. ARKF - Drawdown Comparison

The maximum XLV drawdown since its inception was -39.17%, smaller than the maximum ARKF drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for XLV and ARKF.

Drawdown Indicators

	XLV	ARKF	Difference
Max Drawdown Largest peak-to-trough decline	-39.17%	-78.63%	+39.46%
Max Drawdown (1Y) Largest decline over 1 year	-10.47%	-38.50%	+28.03%
Max Drawdown (3Y) Largest decline over 3 years	-17.11%	-38.50%	+21.39%
Max Drawdown (5Y) Largest decline over 5 years	-17.11%	-75.30%	+58.19%
Max Drawdown (10Y) Largest decline over 10 years	-28.40%	—	—
Current Drawdown Current decline from peak	-3.59%	-38.77%	+35.18%
Average Drawdown Average peak-to-trough decline	-7.12%	-34.95%	+27.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.37%	21.00%	-16.63%

Volatility

XLV vs. ARKF - Volatility Comparison

The current volatility for State Street Health Care Select Sector SPDR ETF (XLV) is 4.90%, while ARK Fintech Innovation ETF (ARKF) has a volatility of 10.36%. This indicates that XLV experiences smaller price fluctuations and is considered to be less risky than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XLV	ARKF	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.90%	10.36%	-5.46%
Volatility (6M) Calculated over the trailing 6-month period	10.60%	25.14%	-14.54%
Volatility (1Y) Calculated over the trailing 1-year period	15.03%	33.69%	-18.66%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.75%	42.87%	-28.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.58%	39.77%	-23.19%

XLV vs. ARKF - Expense Ratio Comparison

XLV has a 0.08% expense ratio, which is lower than ARKF's 0.75% expense ratio.

Dividends

XLV vs. ARKF - Dividend Comparison

XLV's dividend yield for the trailing twelve months is around 1.63%, more than ARKF's 0.11% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARKF ARK Fintech Innovation ETF	0.11%	0.09%	0.00%	0.00%	0.00%	0.00%	0.37%	1.25%	0.00%	0.00%	0.00%	0.00%
XLV State Street Health Care Select Sector SPDR ETF	1.63%	1.60%	1.67%	1.59%	1.47%	1.33%	1.49%	2.17%	1.57%	1.47%	1.60%	1.43%

Frequently Asked Questions

Can I hold both XLV and ARKF in my portfolio?

XLV and ARKF have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XLV or ARKF?

ARKF has higher volatility (10.36%) compared to XLV (4.90%). In terms of maximum drawdown, XLV dropped -39.17% vs ARKF's -78.63%.

Which ETF is better, XLV or ARKF?

On 5-year performance, XLV leads with 6.00% vs -5.06% for ARKF. On fees, XLV is cheaper at 0.08% per year. On volatility, XLV has been the lower-risk option at 4.90%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, XLV or ARKF?

Over the 5-year period, XLV has performed better with a 6.00% return vs -5.06%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, XLV or ARKF?

XLV is cheaper with a 0.08% expense ratio, compared with 0.75% for ARKF.

Which ETF pays a higher dividend yield, XLV or ARKF?

XLV has the higher dividend yield at 1.63%, compared with 0.11% for ARKF.

What is the main difference between XLV and ARKF?

XLV is categorized as Health & Biotech Equities, while ARKF is Blockchain. They also come from different issuers: State Street and ARK. Their fees differ too: 0.08% for XLV and 0.75% for ARKF.

Which has better risk-adjusted returns?

XLV currently has the higher Sharpe Ratio (0.97 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.